18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography is useful in diagnosing, staging, and assessing resectability and metabolic response in pancreatic cancer. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in pancreatic cancer.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pancreatic Cancer

  • Senthil Raja,
  • Hian Liang Huang,
  • Cindy Leung,
  • Gopinath Gnanasegaran

摘要

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography is useful in diagnosing, staging, and assessing resectability and metabolic response in pancreatic cancer. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in pancreatic cancer.